Table 4.

Genotype frequencies of the EBF1 polymorphism in HLA-DRB1*1501 positive and negative multiple sclerosis patients.

EBF rs1368297	AA	AT	TT	A	T
DRB1*1501+ MS patients*	51	53	19	155	91
(n = 123)	41.5%	43.1%	15.4%	63%	37%
DRB1*1501- MS patients	74	115	39	263	193
(n = 228)	32.5%	50.4%	17.1%	57.7%	42.3%
Controls	149	267	108	565	483
(n = 524)	28.4%	50.9%	20.6%	53.9%	46.1%

* AA vs. (AT+TT): p = 0.005; OR (95% CI) = 1.78 (1.16–2.73)

A vs. T: p = 0.01; OR (95% CI) = 1.46 (1.08–1.96)